Vanguard Group Inc Cytokinetics Inc Put Options Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CYTK
# of Institutions
401Shares Held
115MCall Options Held
3.46MPut Options Held
1.86M-
Black Rock Inc. New York, NY14.7MShares$579 Million0.02% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.8MShares$424 Million0.31% of portfolio
-
State Street Corp Boston, MA6.17MShares$243 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA2.84MShares$112 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.72MShares$107 Million2.09% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.72B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...